RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nanoform Finland Oyj - Stock

Nanoform Finland Oyj Revenue 2024

Nanoform Finland Oyj Revenue

5.96 M EUR

Ticker

NANOFH.HE

ISIN

FI4000330972

WKN

A2P5N7

In 2024, Nanoform Finland Oyj's sales reached 5.96 M EUR, a 132.18% difference from the 2.57 M EUR sales recorded in the previous year.

The Nanoform Finland Oyj Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2026e14.14-92,00
2025e9.7-134,16
2024e5.96-218,30
20232.57-506,86
20223.49-311,49
20211.95-613,88
20200.69-1755,42
20190.05-10008,68
20180.24-521,43
20170.07-802,43

Nanoform Finland Oyj Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Nanoform Finland Oyj, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Nanoform Finland Oyj from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Nanoform Finland Oyj’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Nanoform Finland Oyj. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Nanoform Finland Oyj’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Nanoform Finland Oyj’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Nanoform Finland Oyj’s growth potential.

Nanoform Finland Oyj Revenue, EBIT and net profit per share

DateNanoform Finland Oyj RevenueNanoform Finland Oyj EBITNanoform Finland Oyj Net Income
2026e14.14 M undefined-13.33 M undefined-15.15 M undefined
2025e9.7 M undefined-16.41 M undefined-16.83 M undefined
2024e5.96 M undefined-18.18 M undefined-18.55 M undefined
20232.57 M undefined-22.48 M undefined-20.76 M undefined
20223.49 M undefined-21.41 M undefined-22.07 M undefined
20211.95 M undefined-19.71 M undefined-19.69 M undefined
2020686,750 undefined-19.42 M undefined-19.44 M undefined
201949,090 undefined-7.34 M undefined-7.55 M undefined
2018235,000 undefined-1.99 M undefined-2.07 M undefined
201765,000 undefined-486,120 undefined-521,270 undefined

Nanoform Finland Oyj stock margins

The Nanoform Finland Oyj margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nanoform Finland Oyj. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nanoform Finland Oyj.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Nanoform Finland Oyj's sales revenue. A higher gross margin percentage indicates that the Nanoform Finland Oyj retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Nanoform Finland Oyj's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Nanoform Finland Oyj's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Nanoform Finland Oyj's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Nanoform Finland Oyj. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Nanoform Finland Oyj's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Nanoform Finland Oyj Margin History

Nanoform Finland Oyj Gross marginNanoform Finland Oyj Profit marginNanoform Finland Oyj EBIT marginNanoform Finland Oyj Profit margin
2026e-506.86 %-94.29 %-107.11 %
2025e-506.86 %-169.27 %-173.56 %
2024e-506.86 %-305.08 %-311.37 %
2023-506.86 %-875.73 %-808.73 %
2022-311.49 %-613.9 %-632.99 %
2021-613.88 %-1,008.18 %-1,007.38 %
2020-1,755.42 %-2,828.21 %-2,830.92 %
2019-10,008.68 %-14,960.83 %-15,387.09 %
2018-521.43 %-845.53 %-882.68 %
2017-802.43 %-747.88 %-801.95 %

Nanoform Finland Oyj Aktienanalyse

What does Nanoform Finland Oyj do?

Nanoform Finland Plc is a Finnish company operating in the pharmaceutical industry. The company was founded in 2015 and is headquartered in Helsinki. Nanoform's business model is to increase the bioavailability of drugs. Bioavailability refers to the amount of a drug that is actually absorbed by the body. Drug development is a time-consuming and costly process. However, many drugs do not provide sufficient effectiveness due to their poor bioavailability. Nanoform has developed a technology that can improve the bioavailability of drugs. The technology is called "CSP Technology" (Cryo-Spray-Particle-Technology). This is a process in which drugs are broken down into tiny particles and then frozen. Through this process, the particles can be better absorbed by body cells and thus effectively release their effects. The company is divided into different divisions, each targeting specific areas of the pharmaceutical industry. One division is specialized in the development of generics, which are imitation products of existing drugs. Another division focuses on the production of active ingredients for new drugs that are not yet available. Nanoform is also capable of improving already approved drugs through the application of CSP technology. The company works closely with its customers to develop tailored solutions for their specific drugs. This includes comprehensive consulting, analysis of the drug, and the creation of special particles that are customized to the customer's needs. Nanoform's products are known for their high quality and effectiveness in treating diseases. Customers worldwide rely on the company to make their drugs more effective and achieve better results for their patients. Nanoform continuously works on the further development and improvement of its technology and products. The company invests heavily in research and development of new solutions for the pharmaceutical industry. Currently, the company is also planning to expand into the Asian market. Nanoform is an innovative company that shapes the future of the pharmaceutical industry. Through its innovative CSP technology and industry know-how, Nanoform achieves a new dimension in the production of medicines and thus enhances their effectiveness. Nanoform Finland Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Nanoform Finland Oyj's Sales Figures

The sales figures of Nanoform Finland Oyj originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Nanoform Finland Oyj’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Nanoform Finland Oyj's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Nanoform Finland Oyj’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Nanoform Finland Oyj Stock

How much revenue did Nanoform Finland Oyj generate this year?

Nanoform Finland Oyj has achieved a revenue of 5.96 M EUR this year.

How much was the turnover of the company Nanoform Finland Oyj compared to the previous year?

The revenue of Nanoform Finland Oyj has increased by 132.18% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Nanoform Finland Oyj?

The revenue of Nanoform Finland Oyj is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Nanoform Finland Oyj measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Nanoform Finland Oyj so important for investors?

The revenue of Nanoform Finland Oyj is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Nanoform Finland Oyj pay?

Over the past 12 months, Nanoform Finland Oyj paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanoform Finland Oyj is expected to pay a dividend of 0 EUR.

What is the dividend yield of Nanoform Finland Oyj?

The current dividend yield of Nanoform Finland Oyj is .

When does Nanoform Finland Oyj pay dividends?

Nanoform Finland Oyj pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nanoform Finland Oyj?

Nanoform Finland Oyj paid dividends every year for the past 0 years.

What is the dividend of Nanoform Finland Oyj?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nanoform Finland Oyj located?

Nanoform Finland Oyj is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nanoform Finland Oyj kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nanoform Finland Oyj from 7/1/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Nanoform Finland Oyj pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Nanoform Finland Oyj in the year 2023?

In the year 2023, Nanoform Finland Oyj distributed 0 EUR as dividends.

In which currency does Nanoform Finland Oyj pay out the dividend?

The dividends of Nanoform Finland Oyj are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nanoform Finland Oyj

Our stock analysis for Nanoform Finland Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanoform Finland Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.